Valentina Bordin

Ms. Valentina Bordin

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in NeuroImage: Clinical
Verified
Journal Article
Open access
LMLuca Melazzini
Luca Melazzini
CMClare E. Mackay
Clare E. Mackay
VBValentina Bordin
Valentina Bordin
SSSana Suri
Sana Suri
EZEnikő Zsoldos
Enikő Zsoldos
LGLudovica Griffanti
Ludovica Griffanti
White matter hyperintensities (WMHs) on T2-weighted images are radiological signs of cerebral small vessel disease. As their total volume is variably associated with cognition, a new approach that integrates multiple radiological criteria is warranted. Location may matter, as periventricular WMHs have been shown to be associated with cognitive impairments. WMHs that appear as hypointense in T1-weighted images (T1w) may also indicate the most severe component of WMHs. We developed an automatic method that sub-classifies WMHs into four categories (periventricular/deep and T1w-hypointense/nonT1w-hypointense) using MRI data from 684 community-dwelling older adults from the Whitehall II study. To test if location and intensity information can impact cognition, we derived two general linear models using either overall or subdivided volumes. Results showed that periventricular T1w-hypointense WMHs were significantly associated with poorer performance in the trail making A (p = 0.011), digit symbol (p = 0.028) and digit coding (p = 0.009) tests. We found no association between total WMH volume and cognition. These findings suggest that sub-classifying WMHs according to both location and intensity in T1w reveals specific associations with cognitive performance.

17 January 2025 in Bioengineering
Verified
Journal Article
Open access
PDF file
DCDavide Coluzzi
Davide Coluzzi
VBValentina Bordin
Valentina Bordin
MRMassimo Walter Rivolta
Massimo Walter Rivolta
IFIgor Fortel
Igor Fortel
LZLiang Zhan
Liang Zhan
Giuseppe BaselliGiuseppe Baselli
Giuseppe Baselli
As the leading cause of dementia worldwide, Alzheimer’s Disease (AD) has prompted significant interest in developing Deep Learning (DL) approaches for its classification. However, it currently remains unclear whether these models rely on established biological indicators. This work compares a novel DL model using structural connectivity (namely, BC-GCN-SE adapted from functional connectivity tasks) with an established model using structural magnetic resonance imaging (MRI) scans (namely, ResNet18). Unlike most studies primarily focusing on performance, our work places explainability at the forefront. Specifically, we define a novel Explainable Artificial Intelligence (XAI) metric, based on gradient-weighted class activation mapping. Its aim is quantitatively measuring how effectively these models fare against established AD biomarkers in their decision-making. The XAI assessment was conducted across 132 brain parcels. Results were compared to AD-relevant regions to measure adherence to domain knowledge. Then, differences in explainability patterns between the two models were assessed to explore the insights offered by each piece of data (i.e., MRI vs. connectivity). Classification performance was satisfactory in terms of both the median true positive (ResNet18: 0.817, BC-GCN-SE: 0.703) and true negative rates (ResNet18: 0.816; BC-GCN-SE: 0.738). Statistical tests (p < 0.05) and ranking of the 15% most relevant parcels revealed the involvement of target areas: the medial temporal lobe for ResNet18 and the default mode network for BC-GCN-SE. Additionally, our findings suggest that different imaging modalities provide complementary information to DL models. This lays the foundation for bioengineering advancements in developing more comprehensive and trustworthy DL models, potentially enhancing their applicability as diagnostic support tools for neurodegenerative diseases.

1 August 2021 in NeuroImage
Verified
Journal Article
Open access
VBValentina Bordin
Valentina Bordin
IBIlaria Bertani
Ilaria Bertani
IMIrene Mattioli
Irene Mattioli
VSVaanathi Sundaresan
Vaanathi Sundaresan
PMPaul McCarthy
Paul McCarthy
LGLudovica Griffanti
Ludovica Griffanti
Large scale neuroimaging datasets present the possibility of providing normative distributions for a wide variety of neuroimaging markers, which would vastly improve the clinical utility of these measures. However, a major challenge is our current poor ability to integrate measures across different large-scale datasets, due to inconsistencies in imaging and non-imaging measures across the different protocols and populations. Here we explore the harmonisation of white matter hyperintensity (WMH) measures across two major studies of healthy elderly populations, the Whitehall II imaging sub-study and the UK Biobank. We identify pre-processing strategies that maximise the consistency across datasets and utilise multivariate regression to characterise study sample differences contributing to differences in WMH variations across studies. We also present a parser to harmonise WMH-relevant non-imaging variables across the two datasets. We show that we can provide highly calibrated WMH measures from these datasets with: (1) the inclusion of a number of specific standardised processing steps; and (2) appropriate modelling of sample differences through the alignment of demographic, cognitive and physiological variables. These results open up a wide range of applications for the study of WMHs and other neuroimaging markers across extensive databases of clinical data.

11 July 2023 in NeuroImage
Verified
Journal Article
Open access
VBValentina Bordin
Valentina Bordin
APAlice Pirastru
Alice Pirastru
Niels BergslandNiels Bergsland
Niels Bergsland
MCMarta Cazzoli
Marta Cazzoli
Giuseppe BaselliGiuseppe Baselli
Giuseppe Baselli
FBFrancesca Baglio
Francesca Baglio
Quantitative Susceptibility Mapping (QSM) is a recent MRI-technique able to quantify the bulk magnetic susceptibility of myelin, iron, and calcium in the brain. Its variability across different acquisition parameters has prompted the need for standardisation across multiple centres and MRI vendors. However, a high level of agreement between repeated imaging acquisitions is equally important. With this study we aimed to assess the inter-scan repeatability of an optimised multi-echo GRE sequence in 28 healthy volunteers. We extracted and compared the susceptibility measures from the scan and rescan acquisitions across 7 bilateral brain regions (i.e., 14 regions of interest (ROIs)) relevant for neurodegeneration. Repeatability was first assessed while reconstructing QSM with a fixed number of echo times (i.e., 8). Excellent inter-scan repeatability was found for putamen, globus pallidus and caudate nucleus, while good performance characterised the remaining structures. An increased variability was instead noted for small ROIs like red nucleus and substantia nigra. Secondly, we assessed the impact exerted on repeatability by the number of echoes used to derive QSM maps. Results were impacted by this parameter, especially in smaller regions. Larger brain structures, on the other hand, showed more consistent performance. Nevertheless, with either 8 or 7 echoes we managed to obtain good inter-scan repeatability on almost all ROIs. These findings indicate that the designed acquisition/reconstruction protocol has wide applicability, particularly in clinical or research settings involving longitudinal acquisitions (e.g. rehabilitation studies).

29 July 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
VBValentina Bordin
Valentina Bordin
IBIlaria Bertani
Ilaria Bertani
IMIrene Mattioli
Irene Mattioli
VSVaanathi Sundaresan
Vaanathi Sundaresan
PMPaul McCarthy
Paul McCarthy
LGLudovica Griffanti
Ludovica Griffanti
Large scale neuroimaging datasets present the possibility of providing normative distributions for a wide variety of neuroimaging markers, which would vastly improve the clinical utility of these measures. However, a major challenge is our current poor ability to integrate measures across different large-scale datasets, due to inconsistencies in imaging and non-imaging measures across the different protocols and populations. Here we explore the harmonisation of white matter hyperintensity (WMH) measures across two major studies of healthy elderly populations, the Whitehall II imaging sub-study and the UK Biobank. We identify pre-processing strategies that maximise the consistency across datasets and utilise multivariate regression to characterise sample differences contributing to study-level differences in WMH variations. We also present a parser to harmonise WMH-relevant non-imaging variables across the two datasets. We show that we can provide highly calibrated WMH measures from these datasets with: (1) the inclusion of a number of specific standardised processing steps; and (2) appropriate modelling of sample differences through the alignment of demographic, cognitive and physiological variables. These results open up a wide range of applications for the study of WMHs and other neuroimaging markers across extensive databases of clinical data. HIGHLIGHTS We harmonised measures of WMHs across two studies on healthy ageing Specific pre-processing strategies can increase comparability across studies Modelling of biological differences is crucial to provide calibrated measures

11 July 2020 in medRxiv
Verified
Preprint
Open access
PDF file
LMLuca Melazzini
Luca Melazzini
CMClare E Mackay
Clare E Mackay
VBValentina Bordin
Valentina Bordin
SSSana Suri
Sana Suri
EZEnikő Zsoldos
Enikő Zsoldos
LGLudovica Griffanti
Ludovica Griffanti
White matter hyperintensities (WMHs) on T 2 -weighted images are radiological signs of cerebral small vessel disease. As their total volume is variably associated with cognition, a new approach that integrates multiple radiological criteria is warranted. Location may matter, as periventricular WMHs have been shown to be associated with cognitive impairments. WMHs that appear as hypointense in T 1 -weighted images (T 1 w) may also indicate the most severe component of WMHs. We developed an automatic method that classifies WMHs into four categories (periventricular/deep and T 1 w-hypointense/nonT 1 w-hypointense) using MRI data from 684 community-dwelling older adults from the Whitehall II study. To test if location and intensity information can impact cognition, we derived two general linear models using either overall or subdivided volumes. Results showed that periventricular T 1 w-hypointense WMHs were significantly associated with poorer performance in several cognitive tests. We found no association between total WMH volume and cognition. These findings suggest that classifying WMHs according to both location and intensity in T 1 w adds value over and above total WMH volume. HIGHLIGHTS: Heterogeneous measures of WMHs are used in research and clinical practice. Location and image intensity should be considered in the assessment of WMHs. T 1 -hypointense WMHs were found to be associated with poorer cognitive performance. Sub-classes of WMHs provide promising results for translation into the clinic.